Ria. J Neurol 2012;259:2429433. Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009;8:16574. Feldman HH, Maia LF, Mackenzie IR, Forster BB, Martzke J, Woolfenden A. Superficial siderosis: a prospective diagnostic marker of cerebral amyloid angiopathy in Alzheimer disease. Stroke 2008;39:2894897. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging requirements for analysis into compact vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:82238. Zhu YC, Tzourio C, Soumare A, Mazoyer B, Dufouil C, Chabriat H. Severity of dilated Virchow-Robin spaces is related to age, blood stress, and MRI markers of modest vessel disease: a population-based study. Stroke 2010;41:2483490.Glycopyrrolate custom synthesis Charidimou A, Boulouis G, Haley K, et al. White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology 2016;86:50511. Foster-Dingley JC, Moonen JE, van den Berg-Huijsmans AA, et al. Reduce blood pressure and gray matter integrity loss in older persons. J Clin Hypertens 2015;17:63037. Reijn TS, Rikkert MO, van Geel WJ, de Jong D, Verbeek MM. Diagnostic accuracy of ELISA and xMAP technologies for evaluation of amyloid beta(42) and tau proteins. Clin Chem 2007;53:85965.19.20.21.22.23.24.25.26.27.28.29.30.31.32.33.34.Tarasoff-Conway JM, Carare RO, Osorio RS, et al. Clearance systems inside the brain: implications for Alzheimer illness.Calcein Purity & Documentation Nat Rev Neurol 2015;11:45770.PMID:23756629 Attems J, Jellinger K, Thal DR, Van Nostrand W. Review: sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 2011;37:753. Weller RO, Subash M, Preston SD, Mazanti I, Carare RO. Perivascular drainage of amyloid-beta peptides in the brain and its failure in cerebral amyloid angiopathy and Alzheimer’s illness. Brain Pathol 2008;18:25366. Zhang-Nunes SX, Maat-Schieman ML, van Duinen SG, Roos RA, Frosch MP, Greenberg SM. The cerebral beta-amyloid angiopathies: hereditary and sporadic. Brain Pathol 2006;16:309. Shinkai Y, Yoshimura M, Ito Y, et al. Amyloid beta-proteins 1-40 and 1-42(43) within the soluble fraction of extra- and intracranial blood vessels. Ann Neurol 1995;38:42128. Natte R, Yamaguchi H, Maat-Schieman ML, et al. Ultrastructural evidence of early non-fibrillar Abeta42 inside the capillary basement membrane of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch variety. Acta Neuropathol 1999;98:57782. Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM. Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in impacted vessels. J Neuropathol Exp Neurol 1998;57:35359. Maat-Schieman ML, van Duinen SG, Rozemuller AJ, Haan J, Roos RA. Association of vascular amyloid beta and cells on the mononuclear phagocyte program in hereditary cerebral hemorrhage with amyloidosis (Dutch) and Alzheimer illness. J Neuropathol Exp Neurol 1997;56: 27384. Vinters HV, Secor DL, Read SL, et al. Microvasculature in brain biopsy specimens from individuals with Alzheimer’s illness: an immunohistochemical and ultrastructural study. Ultrastruct Pathol 1994;18:33348. Herzig MC, Van Nostrand WE, Jucker M. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol 2006;16:404. Lopera F, Ardilla A, Martinez A, et al. Clinical characteristics of early-onset Alzheimer illness inside a significant kindred with an E280A presenilin-1 mutation. JAMA 1997;277:79399. Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly.
